Representative Work

Health Health

Results

All Representative Work

Representative Work

Nimble Science in its raising of US$ 2 million in a Series A financing round

On April 5, 2023, Nimble Science raised US$ 2 million in a Series A financing round. The company plans to utilize the funding to expand their health test platform, commercial research partnerships and the team.Nimble Science is a digital health company that analyzes data insights for the...

Lead Office: Toronto Date Closed: April 5, 2023 Value: US$2 million

Read more
Representative Work

RetinaLogik Inc. in connection with an investment from Front Row Ventures

On March 1, 2023, RetinaLogik Inc. received an investment from Front Row Ventures for an undisclosed amount. RetinaLogik Inc., aspires to offer healthcare professionals solutions through their software which supports accessibility to eyecare exams.RetinaLogik Inc., founded by Dr. Abdullah...

Lead Office: Toronto Date Closed: March 1, 2023 Value: -

Read more
Representative Work

Nichi-Iko Pharmaceutical Co. in its US$100-million sale to Ellimist Singapore Pte. Ltd.

On February 28, 2023, Nichi-Iko Pharmaceutical Co., Ltd. sold all issued and outstanding shares of its wholly owned subsidiaries, Sagent Pharmaceuticals, based in Wyoming, and Omega Laboratories Ltd., based in Montréal, to Ellimist Singapore Pte. Ltd. for an aggregate purchase price of US$100...

Lead Office: Montreal Date Closed: February 28, 2023 Value: US$100 million

Read more
Representative Work

Clinify Inc. in its $2 million of seed funding

On February 15, 2023, Clinify Inc. received $2 million in seed funding from Thin Air Labs, HaloHealth, and Calgary doctors. Clinify plans to use this funding to support their mission of making healthcare more accessible in Africa.Clinfiy Inc.  is a software company that offers a medical...

Lead Office: Toronto Date Closed: February 15, 2023 Value: $2 million

Read more
Representative Work

Thin Air Labs in connection with Clinify Inc.’s $2 million of seed funding

On February 15, 2023, Clinify Inc. received $2 million in seed funding from Thin Air Labs, HaloHealth, and Calgary doctors. Clinify plans to use this funding to support their mission of making healthcare more accessible in Africa.Clinfiy Inc.  is a software company that offers a medical...

Lead Office: Toronto Date Closed: February 15, 2023 Value: $2 million

Read more
Representative Work

Winterlight Labs in its £7-million business combination with Cambridge Cognition Holdings plc

On January 11, 2023, Winterlight Labs announced that it was acquired by Cambridge Cognition Holdings plc for £7 million. This value is comprised of a cash payment of £3 million and £4 million of Cambridge Cognition shares. Collectively, the companies aspire to create digital health products to...

Lead Office: Toronto Date Closed: January 11, 2023 Value: £7 million

Read more
Representative Work

Neptune Wellness Solutions in the $5.15M sale of its cannabis business to PurCann Pharma

On October 17, 2022, Neptune Wellness Solutions announced it had entered into a binding agreement to sell its cannabis business to PurCann Pharma Inc., a subsidiary of Groupe SiliCycle, a Quebec based company with over 27 years of experience with extracting and purifying active ingredients...

Lead Office: Montreal Date Closed: -- Value: $5.15 million

Read more
Representative Work

Mind Medicine in its US$30 million public offering

On September 30, 2022, Mind Medicine (MindMed) Inc. issued 7,058,823 common shares, together with accompanying warrants to purchase 7,058,823 common shares in an underwritten public offering for gross proceeds of approximately US$30 million.MindMed is a clinical stage biopharmaceutical...

Lead Office: Vancouver Date Closed: September 30, 2022 Value: US$30 million

Read more
Representative Work

LifeWorks in its $2.9 billion acquisition by TELUS

On September 1, 2022, LifeWorks completed its binding agreement with TELUS Corporation under which TELUS has acquired all of the issued and outstanding common shares of LifeWorks. The transaction represents a premium of 80% and 89% to the closing price and 20-day VWAP, respectively, of...

Lead Office: Toronto Date Closed: September 1, 2022 Value: $2.9 billion

Read more
Representative Work

Interaxon in its US$9.5 million Series C financing round

On August 11, 2022, Interaxon announced it had closed its US$9.5 million Series C financing round led by BDC Capital, Alabaster and Export Development Canada with participation from Phyto Partners, Iter Investments, Intretech(HK) Co, and The Clavis Foundation. With this financing round,...

Lead Office: Toronto Date Closed: August 11, 2022 Value: US$9.5 million

Read more